: iStockAnalyst.com Symbols Feed

Authentidate: Significant Opportunities For Revenue Growth

Mon, 09 Nov 2009 14:12:26 GMT

Authentidate: Significant Opportunities for Revenue Growth Business Overview: Authentidate provides software solutions for electronic medical records. They service this through 3 methods: Software solutions for care providers, home telehealth devices, and patient discharge solutions.[More...]

Authentidate (ADAT): Remote Patient Monitoring Presents Significant Opportunity

Fri, 06 Feb 2009 14:40:00 GMT

Authentidate Holding Corp (ncm: ADAT) $0.27- Authentidate is attractively positioned to benefit from the expected flood of spending aimed at modernizing healthcare IT. Remote patient monitoring, also known as telehealth, is one area where Authentidate stands to capitalize due to its unique and superior product solution. Patient home monitoring is expected to be a $12 billion industry by 2012. ADAT will earn $120M in revenue if it achieves just 1% penetration. This compares to $6M in revenue Authentidate earned last fiscal year. There are a decent number of patient monitoring devices deployed currently, yet very few have actual “telemedicine” functionality, whereby a patient’s vitals are electronically transmitted to the healthcare provider coupled with any patient instructions subsequently relayed back to the patient. According to an InMedica study, there were less than 1 million[More...]

Authentidate (ADAT): Exploding Demand for Shares

Sun, 27 Jul 2008 23:42:00 GMT

Authentidate Holding Corp. (Nasdaq: ADAT) $0.78- Authentidate has been on a tear recently with shares up 189% from an all-time low of $0.27 reached on July 7. In May, I wrote about ADAT when it was trading at $0.43 and recommended the stock since I believed it was undervalued.